Godavari Drugs Share Price

Godavari Drugs

CMP as on17-Jan-22 15:52

₹ 65.60
-0.95 -1.43%

Open

₹ 68.10

Turnover (lac)

₹ 9

Prev. Close

₹ 66.55

Day's Vol (shares)

₹ 15,971

Day's Range

₹ 65.00
₹ 68.10

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Nov-2021 - -
Quarterly Results Outcome of the Board Meeting held on 12.11.2021 for approval of unaudited financials for the quarter ended 30.09.2021 (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 06-Aug-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve Unaudited Financial Statements for the quarter ended 30.06.2021. Outcome of Board Meeting held on 14.08.2021 for approval of Unaudited Financial Statement Unaudited Financial Results for the quarter ended 30.06.2021 (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 10-Jun-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2021 ,inter alia, to consider and approve The Audited Financials for the Quarter and Financial Year ended 31.03.2021 Outcome of the Board Meeting held on 16.06.2021 to approve the Audited quarterly and Financial year ended results as on 31.03.2021. (As Per BSE Announcement Dated on 16/06/2021)
Board Meeting - 06-May-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2021 ,inter alia, to consider and approve Appointment of Ms. Rashmi Agarwal as Company Secretary, Compliance Officer and KMP of the Company.
Board Meeting - 04-Feb-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve GODAVARI DRUGS LIMITED.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Pursuant to Regulations 29 of SEBI (LODR) regulation, 2015, be and is hereby given that the Meeting of the Board of Directors of the Company will be held on Friday, February 12, 2021, at the Registered Office of the Company through video conference, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended 31st December, 2020. Unaudited Financial Results for quarter / nine month ended 31.12.2020. Unaudited Financial Results for quarter / nine month ended 31.12.2020. (AS Per BSE Announcement Dated on 12.02.2021)
Open ZERO Brokerage Demat Account Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity